Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study

Otsuka Pharmaceutical and Ionis Pharmaceuticals said on Tuesday their experimental drug met the main ​goal of a late-stage study in patients ‌with a rare inherited form of amyotrophic lateral sclerosi...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。